We are live on ! Find out more
HRCM

Hood River Capital Management Portfolio holdings

AUM $9.98B
1-Year Est. Return 145.42%
This Fund
S&P 500
This Quarter Est. Return
+18.13%
1 Year Est. Return
+145.42%
3 Year Est. Return
+584.57%
5 Year Est. Return
+927.1%
10 Year Est. Return
+12,185.37%
AUM
$6.19B
AUM Growth
+$1.37B
Cap. Flow
+$709M
Cap. Flow %
11.45%
Top 10 Hldgs %
24.49%
Holding
177
New
33
Increased
95
Reduced
14
Closed
35

Top Buys

Rank Stock Value
1
SMTC icon
Semtech
SMTC
+$125M
2
QXO
QXO Inc
QXO
+$114M
3
IOVA icon
Iovance Biotherapeutics
IOVA
+$51.3M
4
OLLI icon
Ollie's Bargain Outlet
OLLI
+$50.6M
5
WAL icon
Western Alliance Bancorporation
WAL
+$50M

Top Sells

Rank Stock Value
1
FTAI icon
FTAI Aviation
FTAI
+$129M
2
RMBS icon
Rambus
RMBS
+$127M
3
ONTO icon
Onto Innovation
ONTO
+$84M
4
CAMT icon
Camtek
CAMT
+$73.3M
5
VRT icon
Vertiv
VRT
+$65.6M

Sector Composition

Rank Sector Weight
1 Industrials 26.95%
2 Technology 25.57%
3 Healthcare 24.26%
4 Consumer Discretionary 7.87%
5 Financials 4.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VKTX icon
51
Viking Therapeutics
VKTX
$4.02B
$51.6M 0.83%
815,678
+101,100
+14% +$5.93M
EXLS icon
52
EXL Service
EXLS
$5.32B
$51M 0.82%
+1,337,786
New +$46.7M
CIEN icon
53
Ciena
CIEN
$54.9B
$49.6M 0.8%
+805,981
New +$42.5M
CUBI icon
54
Customers Bancorp
CUBI
$2.78B
$48.8M 0.79%
1,049,616
+500,553
+91% +$26.1M
BHVN icon
55
Biohaven
BHVN
$2.19B
$45.1M 0.73%
902,888
+533,986
+145% +$20.8M
VSXY
56
Victoria's Secret
VSXY
$7.95B
$44.6M 0.72%
+1,735,948
New +$36.8M
ITCI
57
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$43.9M 0.71%
599,991
+112,473
+23% +$8.45M
CRNX icon
58
Crinetics Pharmaceuticals
CRNX
$8.93B
$42.7M 0.69%
834,912
+424,570
+103% +$21.9M
ALHC icon
59
Alignment Healthcare
ALHC
$2.86B
$41.9M 0.68%
3,547,783
+441,093
+14% +$4.17M
FIP icon
60
FTAI Infrastructure
FIP
$508M
$41.6M 0.67%
4,439,273
+1,482,110
+50% +$13.8M
VRNA
61
DELISTED
Verona Pharma
VRNA
$41.3M 0.67%
1,433,934
+371,478
+35% +$9.14M
DOCN icon
62
DigitalOcean
DOCN
$15.3B
$41.1M 0.66%
1,018,042
+194,386
+24% +$6.93M
TGTX icon
63
TG Therapeutics
TGTX
$7.52B
$38.1M 0.62%
1,630,349
+57,420
+4% +$1.25M
GENI icon
64
Genius Sports
GENI
$2.1B
$37.1M 0.6%
4,730,748
+2,703,875
+133% +$18.8M
EVH icon
65
Evolent Health
EVH
$444M
$36.5M 0.59%
1,292,379
-325,073
-20% -$8.38M
FN icon
66
Fabrinet
FN
$18.9B
$35.8M 0.58%
+151,504
New +$35.1M
SPXC icon
67
SPX Corp
SPXC
$10.6B
$34.4M 0.56%
215,802
+28,265
+15% +$4.27M
SDHC icon
68
Smith Douglas Homes
SDHC
$116M
$34.2M 0.55%
+903,951
New +$29M
AMSC icon
69
American Superconductor
AMSC
$1.5B
$33.8M 0.55%
1,431,940
-303,074
-17% -$6.99M
TFII icon
70
TFI International
TFII
$11.4B
$33.5M 0.54%
244,864
+29,848
+14% +$4.41M
MLTX icon
71
MoonLake Immunotherapeutics
MLTX
$1.47B
$32.6M 0.53%
+646,662
New +$30.3M
IMVT icon
72
Immunovant
IMVT
$8.24B
$32.6M 0.53%
+1,143,567
New +$33.7M
RYTM icon
73
Rhythm Pharmaceuticals
RYTM
$7.95B
$32.2M 0.52%
+614,598
New +$29.4M
BASE
74
DELISTED
Couchbase
BASE
$32M 0.52%
1,982,074
+352,181
+22% +$6.1M
PSN icon
75
Parsons
PSN
$4.93B
$31.9M 0.52%
+307,889
New +$27.6M
1 2
3
4 5

Similar funds

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return
URS
Utah Retirement Systems Salt Lake City, Utah $9.78B AUM 28.72% 1-Year Est. Return

Hood River Capital Management's Q3 2024 Portfolio in Review

As of Q3 2024, Hood River Capital Management held 177 positions worth $6.19B, up 28% from $4.83B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Hood River Capital Management deployed $709M of net new capital in Q3 2024, opening 33 new positions and adding to 95 existing holdings. Its largest new stake was Semtech: 3,390,299 shares worth $155M.

By sector, the portfolio is most concentrated in Industrials at 27% of assets, down from 29% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was FTAI Aviation, an estimated $129M trimmed.

  • Hood River Capital Management's largest Q3 2024 buy was Semtech: 3,390,299 shares worth $155M.
  • Hood River Capital Management added most to Iovance Biotherapeutics in Q3 2024, an estimated $51.3M increase.
  • Hood River Capital Management's biggest Q3 2024 reduction was FTAI Aviation, cutting an estimated $129M.
  • Hood River Capital Management fully exited Rambus in Q3 2024, selling an estimated $127M.
  • Hood River Capital Management's ten largest holdings make up 24% of its $6.19B portfolio in Q3 2024.
  • Hood River Capital Management opened 33 new positions and closed 35 in Q3 2024.
  • Hood River Capital Management's portfolio value rose 28% quarter-over-quarter to $6.19B.

Based on Hood River Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.